Michael Hölzel
University of Bonn · 335 works · 10,776 citations · h-index 50
Top works
- Immune Cell–Poor Melanomas Benefit from PD-1 Blockade after Targeted Type I IFN Activation
- MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling
- Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation
- Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma
- Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells
- Chemotherapeutic Drugs Inhibit Ribosome Biogenesis at Various Levels
- ALK Mutations Conferring Differential Resistance to Structurally Diverse ALK Inhibitors
- ZNF423 Is Critically Required for Retinoic Acid-Induced Differentiation and Is a Marker of Neuroblastoma Outcome
- Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance?
- IL-36γ (IL-1F9) Is a Biomarker for Psoriasis Skin Lesions
- Dissection of transcriptional programmes in response to serum and c-Myc in a human B-cell line
- The experimental power of FR900359 to study Gq-regulated biological processes
- Tissue-resident memory CD8+ T cells promote melanoma–immune equilibrium in skin
- NF1 Is a Tumor Suppressor in Neuroblastoma that Determines Retinoic Acid Response and Disease Outcome
- Mammalian WDR12 is a novel member of the Pes1–Bop1 complex and is required for ribosome biogenesis and cell proliferation
- Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance
- Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer Immunotherapy
- MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment
- Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma
- Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity